High-dose-rate Brachytherapy Monotherapy in Patients With Localised Prostate Cancer: Dose Modelling and Optimisation Using Computer Algorithms.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published Date:

Abstract

AIMS: Interstitial high-dose-rate brachytherapy (HDR-BT) is an effective therapy modality for patients with localized prostate carcinoma. The objectives of the study were to optimise the therapy regime variables using two models: response surface methodology (RSM) and artificial neural network (ANN).

Authors

  • K Dabic-Stankovic
    IMC Affidea, Banja Luka, Republic of Srpska, Bosnia and Herzegovina; Faculty of Medicine, University of Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
  • K Rajkovic
    Academy of Applied Preschool Teaching and Health Studies, Krusevac, Serbia; Bijeljina University, Republic of Srpska, Bosnia and Herzegovina. Electronic address: katar1970@yahoo.com.
  • J Stankovic
    Bijeljina University, Republic of Srpska, Bosnia and Herzegovina; Academy for Applied Studies Belgrade, The College of Health Sciences, Zemun, Serbia. Electronic address: jovs60@gmail.com.
  • G Marosevic
    IMC Affidea, Banja Luka, Republic of Srpska, Bosnia and Herzegovina; Faculty of Medicine, University of Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
  • G Kolarevic
    IMC Affidea, Banja Luka, Republic of Srpska, Bosnia and Herzegovina; Faculty of Medicine, University of Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
  • B Pavicar
    IMC Affidea, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.